SCHEMBL4730195

SCHEMBL4730195

CCOC(=O)C(=O)C1C(=O)c2cc(Cl)ccc2OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPG P10696 1/20 0.41
HTT P42858 2/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
USP2 O75604 1/20 0.39
ALDH1A1 P00352 4/20 0.39
TP53 P04637 1/20 0.39
ABCC9 O60706 3/20 0.37
GAA P10253 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
LMNA P02545 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAOB P27338 2/20 0.36
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4728256 0.91 ALPG (0.41) ALPGHTTMAPTTSHRUSP2
SCHEMBL4726120 0.86 TDP2 (0.39) HTTMAPTTSHRALDH1A1GAA
SCHEMBL2171555 0.83 ALDH1A1 (0.45) MAPTTSHRALDH1A1L3MBTL1KDM4E
SCHEMBL4730197 0.81 MAPK1 (0.40) ALPGHTTMAPTTSHRALDH1A1
SCHEMBL4727314 0.81 LMNA (0.40) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL4728259 0.79 CYP11B2 (0.40) ALPGHTTMAPTTSHRUSP2
SCHEMBL4726624 0.79 ALDH1A1 (0.34) MAPTALDH1A1GAATDP1L3MBTL1
SCHEMBL4726886 0.79 TDP2 (0.41) HTTMAPTTSHRALDH1A1GAA
SCHEMBL4784487 0.78 ALDH1A1 (0.40) MAPTUSP2ALDH1A1TP53GAA
SCHEMBL4730667 0.77 CNR2 (0.37) MAPTALDH1A1L3MBTL1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035356-A2 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LIMITED (IN) 2008-03-27 WO disclosed